Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 139,035 |
|
|||||
| News | (1) | ||||||
| Day High | 3.39 | Low High |
|||||
| Day Low | 3.0756 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Turnstone Biologics Corporation | TSBX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.07 | 2.19% | 3.27 | 17:44:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.19 | 3.0756 | 3.39 | 3.25 | 3.20 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,656 | 139,035 | US$ 3.21 | US$ 446,239 | - | 1.625 - 13.20 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:44:12 | formt | 200 | US$ 3.27 | USD |
Turnstone Biologics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 75.05M | 23.09M | - | 19.31M | -55.2M | -2.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Turnstone Biologics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TSBX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.60 | 3.39 | 2.51 | 2.86 | 172,541 | 0.67 | 25.77% |
| 1 Month | 3.26 | 3.8782 | 2.46 | 2.97 | 168,595 | 0.01 | 0.31% |
| 3 Months | 2.20 | 5.75 | 2.00 | 3.21 | 185,814 | 1.07 | 48.64% |
| 6 Months | 2.71 | 5.75 | 1.625 | 2.98 | 145,890 | 0.56 | 20.66% |
| 1 Year | 11.40 | 13.20 | 1.625 | 3.92 | 124,671 | -8.13 | -71.32% |
| 3 Years | 11.40 | 13.20 | 1.625 | 3.92 | 124,671 | -8.13 | -71.32% |
| 5 Years | 11.40 | 13.20 | 1.625 | 3.92 | 124,671 | -8.13 | -71.32% |
Turnstone Biologics Description
| Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient¿s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. |
